Empagliflozin improves survival in type 2 diabetes patients with established cardiovascular diseaseEstimated to improve life expectancy by one to 4.5 years according to an analysis of data from a major trial New developments in type 2 diabetes care Montreal diabetes prevention clinic said to be first of its kind in Canada Study examines risk of serious adverse events with SGLT2 inhibitors in type 2 diabetes Finds twofold increases in the risk of lower limb amputation and diabetic ketoacidosis Internal medicine continues to grow as top choice among residents in medical specialties: CAPER Canadian Paediatric Society issues guidance on attention deficit hyperactivity disorder Intended to help primary care providers improve diagnosis and treatment of ADHD A pill to replace injections? My transformation: 10 lessons learned in the last decade working with transgender patients As our society becomes more open and accepting, the general health of the trans community improves. We still have work to do Orilissa: New oral treatment for endometriosis pain Intended for women with moderate to severe pain caused by endometriosis Invokana now indicated to reduce the risk of major cardiovascular events First Previous 83 84 85 86 87 Next Last
